menu
    • menu

    Company profile for Insys Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We have two marketed products, SUBSYS and Dronabinol SG Capsule, which leverage our sublingual spray drug delivery technology and dronabinol formulation and manufacturing capabilities, respectively. In March 2012, we launched Subsys, our proprietary sublingual fentanyl spray for breakthrough cancer pain, or BTCP, in opioid-tolerant patients. In December 2011, we launched Dronabinol SG Capsule, a generic equivalent to Marinol ...
    We have two marketed products, SUBSYS and Dronabinol SG Capsule, which leverage our sublingual spray drug delivery technology and dronabinol formulation and manufacturing capabilities, respectively. In March 2012, we launched Subsys, our proprietary sublingual fentanyl spray for breakthrough cancer pain, or BTCP, in opioid-tolerant patients. In December 2011, we launched Dronabinol SG Capsule, a generic equivalent to Marinol (dronabinol), an approved second-line treatment for chemotherapy-induced nausea and vomiting, or CINV, and anorexia associated with weight loss in patients with AIDS.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Insys TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1333 South Spectrum Blvd, Suite 100 Chandler, AZ 85286
    Telephone
    Telephone
    (602) 910-2617
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.insysrx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SCOTUS declines to review former Insys founder John Kapoor's conviction
    SCOTUS declines to review former Insys founder John Kapoor's conviction

    13 Jun 2022

    // Zachary Brennan ENDPTS

    https://endpts.com/scotus-declines-to-review-former-insys-founder-john-kapoors-conviction/

    Zachary Brennan ENDPTS
    13 Jun 2022
    Share Share
    Ex-Insys execs owe nearly $50M in opioid restitution
    Ex-Insys execs owe nearly $50M in opioid restitution

    30 Nov 2021

    // Fraiser Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/pharma/insys-execs-ordered-to-pay-48-3-million-resitution-subsys-opioid-trial

    Fraiser Kansteiner FIERCEPHARMA
    30 Nov 2021
    Share Share
    National Comprehensive Cancer Network® Adds Monjuvi® (tafasitamab-cxix)
    National Comprehensive Cancer Network® Adds Monjuvi® (tafasitamab-cxix)

    18 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200818005684/en/National-Comprehensive-Cancer-Network%C2%AE-Adds-Monjuvi%C2%AE-tafasitamab-cxix

    BUSINESSWIRE
    18 Aug 2020
    Share Share
    Ex-Insys Sales Rep Evades Prison Over Opioid Bribe Ploy
    Ex-Insys Sales Rep Evades Prison Over Opioid Bribe Ploy

    17 Aug 2020

    // LAW360

    https://www.law360.com/lifesciences/articles/1301483?utm_source=rss&utm_medium=rss&utm_campaign=section

    LAW360
    17 Aug 2020
    Share Share
    Insys Execs Can't Dodge Prison During Appeal, Seek Delay
    Insys Execs Can't Dodge Prison During Appeal, Seek Delay

    02 Jul 2020

    // WWW.LAW360

    https://www.law360.com/lifesciences/articles/1288808

    WWW.LAW360
    02 Jul 2020
    Share Share
    Opioid executive admits to ‘no morals’ ahead of prison term
    Opioid executive admits to ‘no morals’ ahead of prison term

    24 Jan 2020

    // H. Kuchler FINANCIAL TIMES

    https://www.ft.com/insys

    H. Kuchler FINANCIAL TIMES
    24 Jan 2020
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search